JCC: 回结肠切除术后腹腔感染会增加术后克罗恩病复发的风险

2022-07-11 xuyihan MedSci原创

腹腔感染是指一系列腹腔感染性疾病,主要包括腹腔单个脏器的感染(如急性胆囊炎、急性阑尾炎等)、腹膜炎以及腹腔脓肿,也可根据其感染涉及范围和严重程度分为单纯性腹腔感染和复杂性腹腔感染。

在生物制剂时代,大约20-30%的克罗恩病 (CD) 患者患有狭窄或穿透性疾病需要回盲部切除术 (ICR) 。然而,15-20%的患者在接受ICR后出现CD术后复发 (POR)。探索POR 的危险因素可能有助于指导内镜监测和药物使用来防止手术复发。以前的研究表明,年龄较小(<30 岁),主动吸烟,两次或两次以上手术史,以及穿透性或肛周疾病行为与大约 50% 的临床和 80%的内镜POR相关。

POR的发病机制尚未阐明,被认为是多因素的包括免疫激活。术后并发症包括术后发现感染和腹腔内脓毒症并发症(IASC)与早期临床 POR 相关,因此,本项研究旨在评估IASC是否与内窥镜和手术 POR 风险增加有关。

为此,研究人员回顾性研究了 2009 年至 2020 年间接受回结肠切除并进行初次吻合的成年克罗恩病患者。IASC 定义为手术后 90 天内出现吻合口漏或腹腔内脓肿。采用多变量逻辑和 Cox 比例风险模型评估 IASC 对术后回结肠镜检查和长期手术复发时内镜 POR(改良 Rutgeerts 评分≥i2b)的影响。

 

研究结果显示有535名克罗恩病患者(中位年龄 35 岁,22.1% 的积极吸烟者)进行了回结肠切除术和一期吻合术。少数患者(N=47;8.8%)术后出现 IASC。422 名 (78.9%) 患者进行了≥1次术后回结肠镜检查,其中163名 (38.6%) 患者发生内镜 POR。在调整术后复发的其他危险因素后,术后 IASC 与术后复发显着增加的几率相关(aOR:2.45 [1.23-4.97];p=0.01)和内镜检查时间缩短相关(aHR:1.60 [1.04-2.45];p=0.03)。此外,IASC 与手术复发风险增加(aOR:2.3;[1.04-4.87] p=0.03)和无生存时间减少(aHR:2.53 [1.31-4.87];p=0.006)相关。

本项研究证实IASC与克罗恩病的内镜和手术 POR 风险增加有关。除了术后生物预防外,预防 IASC 的术前优化可能有助于降低内镜和手术 POR 的风险。

原始出处:

Salam P Bachour. et al. Intraabdominal septic complications after ileocolic resection increases risk for endoscopic and surgical postoperative Crohn’s disease recurrence. Journal of Crohn's and Colitis.2022.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1877594, encodeId=ff4c18e7594ef, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 12 12:51:04 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028466, encodeId=9fa220284667a, content=<a href='/topic/show?id=c9b38559517' target=_blank style='color:#2F92EE;'>#腹腔感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85595, encryptionId=c9b38559517, topicName=腹腔感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Tue May 09 19:51:04 CST 2023, time=2023-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706577, encodeId=9f451e06577c1, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Mon Oct 03 05:51:04 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231883, encodeId=5e09123188317, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Jul 11 21:47:49 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1877594, encodeId=ff4c18e7594ef, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 12 12:51:04 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028466, encodeId=9fa220284667a, content=<a href='/topic/show?id=c9b38559517' target=_blank style='color:#2F92EE;'>#腹腔感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85595, encryptionId=c9b38559517, topicName=腹腔感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Tue May 09 19:51:04 CST 2023, time=2023-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706577, encodeId=9f451e06577c1, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Mon Oct 03 05:51:04 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231883, encodeId=5e09123188317, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Jul 11 21:47:49 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1877594, encodeId=ff4c18e7594ef, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 12 12:51:04 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028466, encodeId=9fa220284667a, content=<a href='/topic/show?id=c9b38559517' target=_blank style='color:#2F92EE;'>#腹腔感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85595, encryptionId=c9b38559517, topicName=腹腔感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Tue May 09 19:51:04 CST 2023, time=2023-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706577, encodeId=9f451e06577c1, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Mon Oct 03 05:51:04 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231883, encodeId=5e09123188317, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Jul 11 21:47:49 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1877594, encodeId=ff4c18e7594ef, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Wed Apr 12 12:51:04 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2028466, encodeId=9fa220284667a, content=<a href='/topic/show?id=c9b38559517' target=_blank style='color:#2F92EE;'>#腹腔感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85595, encryptionId=c9b38559517, topicName=腹腔感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f13d475, createdName=mashirong, createdTime=Tue May 09 19:51:04 CST 2023, time=2023-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1706577, encodeId=9f451e06577c1, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Mon Oct 03 05:51:04 CST 2022, time=2022-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1231883, encodeId=5e09123188317, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Mon Jul 11 21:47:49 CST 2022, time=2022-07-11, status=1, ipAttribution=)]
    2022-07-11 医鸣惊人

    认真学习了

    0

相关资讯

慢性炎症性皮肤病患者会影响炎症性肠病的发生率吗?

最近一些研究将各种慢性炎症性皮肤病(CISD)与炎症性肠病(IBD)联系起来,但结论不一。我们比较了溃疡性结肠炎(UC)和克罗恩病(CD)在患有CISD的患者与没有CISD的类似人员中的发病率。

Clin Trans Gastroenterology:预防性抗结核治疗与接受抗TNF治疗的克罗恩病患者疾病进展加速有关

克罗恩病(crohn disease,CD),又称局限性回肠炎、局限性肠炎、节段性肠炎和肉芽肿性肠炎、也译为克隆氏病,是一种原因不明的肠道炎症性疾病。

Gastroenterology:接受腹部手术的炎症性肠病患者术前肿瘤坏死因子抑制剂的治疗的安全性分析

克罗恩病在疾病早期对患者的影响并不大,但如果不及时进行治疗,发展到后期则会对患者造成巨大的伤害。一旦发现有相关症状,建议患者尽早到医院进行治疗。

IBD: 克罗恩病患者术后早期生物治疗与较低的内镜复发率和长期结果改善相关

克罗恩病是一种原因不明的肠道炎症性疾病,在胃肠道的任何部位均可发生,但多发于末端回肠和右半结肠。本病和慢性非特异性溃疡性结肠炎两者统称为炎症性肠病(IBD)。

AJG:不同生物制剂对克罗恩病患者回肠和结肠内镜愈合的疗效比较

各类具有医研价值的碳基生物为原料,利用传统技术或现代生物技术制造,作用于人体各类生理症状的预防(保健)、治疗和诊断的各种形态制剂,统称生物制剂。